{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T13:12:24Z","timestamp":1792501944647,"version":"4.5.0"},"reference-count":0,"publisher":"Walter de Gruyter GmbH","issue":"3","license":[{"start":{"date-parts":[[2012,8,28]],"date-time":"2012-08-28T00:00:00Z","timestamp":1346112000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,9,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Accumulation of neurofibrillary tangles (NFT), intracellular inclusions of fibrillar forms of tau, is a hallmark of Alzheimer\u2019s disease. NFT have been considered causative of neuronal death, however, recent evidence challenges this idea. Other species of tau, such as soluble misfolded, hyperphosphorylated, and mislocalized forms, are now being implicated as toxic. Here we review the data supporting soluble tau as toxic to neurons and synapses in the brain and the implications of these data for development of therapeutic strategies for Alzheimer\u2019s disease and other tauopathies.<\/jats:p>","DOI":"10.2478\/s13380-012-0032-y","type":"journal-article","created":{"date-parts":[[2012,8,27]],"date-time":"2012-08-27T01:17:05Z","timestamp":1346030225000},"page":"223-233","source":"Crossref","is-referenced-by-count":227,"title":["Soluble forms of tau are toxic in Alzheimer\u2019s disease"],"prefix":"10.2478","volume":"3","author":[{"given":"Katherine","family":"Kopeikina","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bradley","family":"Hyman","sequence":"additional","affiliation":[{"name":"MassGeneral Institute for Neurodegenerative Disease, Massachusetts General Hospital, Harvard Medical School, Charlestown, Massachusetts, 02129, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tara","family":"Spires-Jones","sequence":"additional","affiliation":[{"name":"MassGeneral Institute for Neurodegenerative Disease, Massachusetts General Hospital, Harvard Medical School, Charlestown, Massachusetts, 02129, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"374","published-online":{"date-parts":[[2012,8,28]]},"container-title":["Translational Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.2478\/s13380-012-0032-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.2478\/s13380-012-0032-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.2478\/s13380-012-0032-y\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.2478\/s13380-012-0032-y\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,2]],"date-time":"2025-09-02T04:13:37Z","timestamp":1756786417000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.2478\/s13380-012-0032-y\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8,28]]},"references-count":0,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2012,8,28]]},"published-print":{"date-parts":[[2012,9,1]]}},"alternative-id":["10.2478\/s13380-012-0032-y"],"URL":"https:\/\/doi.org\/10.2478\/s13380-012-0032-y","relation":{},"ISSN":["2081-6936","2081-3856"],"issn-type":[{"value":"2081-6936","type":"electronic"},{"value":"2081-3856","type":"print"}],"subject":[],"published":{"date-parts":[[2012,8,28]]}}}